Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析

◆英語タイトル:Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2726
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pharmaniaga Berhad (PHARMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharmaniaga Berhad (Pharmaniaga), a member of Boustead Group is an investment holding company. It is an integrated pharmaceutical group that operates across a wide spectrum of the healthcare industry through its subsidiaries. The company carries out logistics and distribution and manufacturing of generic pharmaceuticals; and sales, marketing and distribution of medical products and hospital equipment. Pharmaniaga also operates community pharmacies in Malaysia; and provides pharmaceutical products, diagnostic products and food supplements in Indonesia. The company has manufacturing facilities and logistics and distribution warehouses in Malaysia and Indonesia; and operates across Malaysia, Indonesia, Vietnam and the US. Pharmaniaga is headquartered at Shah Alam in Selangor, Malaysia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Pharmaniaga Berhad – Key Facts 6
Pharmaniaga Berhad – Key Employees 7
Pharmaniaga Berhad – Key Employee Biographies 8
Pharmaniaga Berhad – Major Products and Services 9
Pharmaniaga Berhad – History 10
Pharmaniaga Berhad – Company Statement 12
Pharmaniaga Berhad – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Pharmaniaga Berhad – Business Description 16
Business Segment: Indonesia 16
Overview 16
Performance 16
Business Segment: Logistics and Distribution 16
Overview 16
Performance 16
Business Segment: Manufacturing 16
Overview 16
Performance 17
Geographical Segment: Indonesia 17
Performance 17
Geographical Segment: Malaysia 17
Performance 17
Geographical Segment: Other countries 17
Performance 17
Pharmaniaga Berhad – Corporate Strategy 18
Pharmaniaga Berhad – SWOT Analysis 19
SWOT Analysis – Overview 19
Pharmaniaga Berhad – Strengths 19
Pharmaniaga Berhad – Weaknesses 20
Pharmaniaga Berhad – Opportunities 21
Pharmaniaga Berhad – Threats 22
Pharmaniaga Berhad – Key Competitors 23
Section 3 – Company Financial Ratios 24
Financial Ratios – Capital Market Ratios 24
Financial Ratios – Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios – Interim Ratios 29
Financial Ratios – Ratio Charts 30
Section 4 – Company’s Lifesciences Financial Deals and Alliances 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Pharmaniaga Berhad, Recent Deals Summary 33
Section 5 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Pharmaniaga Berhad, Key Facts 6
Pharmaniaga Berhad, Key Employees 7
Pharmaniaga Berhad, Key Employee Biographies 8
Pharmaniaga Berhad, Major Products and Services 9
Pharmaniaga Berhad, History 10
Pharmaniaga Berhad, Subsidiaries 14
Pharmaniaga Berhad, Key Competitors 23
Pharmaniaga Berhad, Ratios based on current share price 24
Pharmaniaga Berhad, Annual Ratios 25
Pharmaniaga Berhad, Annual Ratios (Cont...1) 26
Pharmaniaga Berhad, Annual Ratios (Cont...2) 27
Pharmaniaga Berhad, Interim Ratios 29
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32
Pharmaniaga Berhad, Recent Deals Summary 33
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Pharmaniaga Berhad, Performance Chart (2013 - 2017) 28
Pharmaniaga Berhad, Ratio Charts 30
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31
Pharmaniaga Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

★海外企業調査レポート[Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • Schneider Electric SE (SU)-エネルギー分野:企業M&A・提携分析
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line comprises automation and control products, building management and securi …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • MTR Corporation Ltd:企業の戦略・SWOT・財務情報
    MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary MTR Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Clydesdale Bank PLC:企業の戦略的SWOT分析
    Clydesdale Bank PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Suncor Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Suncor Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Suncor Energy Inc. (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and ons …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Avesthagen Ltd-医療機器分野:企業M&A・提携分析
    Summary Avesthagen Ltd (Avesthagen) is a life science company that offers preventive personalized healthcare solutions. The company offers bio-nutrition, bio-agriculture and bio-pharmaceutical products. Its bio-nutrition products include validated bio-actives from Indian medicinal plants for prevent …
  • Victory Resources Corporation:企業の戦略・SWOT・財務情報
    Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Johnson Controls International Plc (JCI):電力:M&Aディール及び事業提携情報
    Summary Johnson Controls International Plc (Johnson Controls) is a diversified technology and multi industrial company. It creates intelligent buildings, integrated infrastructure, efficient energy solutions, and next generation transportation systems. The company provides HVAC equipment, HVAC contr …
  • Sonova Holding AG:企業の戦略・SWOT・財務情報
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • New York Power Authority:電力:M&Aディール及び事業提携情報
    Summary New York Power Authority (NYPA) is a state-owned power organization. It generates electricity, and transmits and sells that on wholesale basis. The authority produces the electricity using hydro, gas, and oil sources. Through long-term electricity supply agreement with Astoria Energy II LLC, …
  • Alabama Power Co-エネルギー分野:企業M&A・提携分析
    Summary Alabama Power Company (Alabama Power), a subsidiary of Southern Company, is a vertically-integrated utility that undertakes the generation, transmission, distribution, procurement and sale of electricity. It generates electricity from coal, hydro, natural gas, oil and nuclear sources. Alabam …
  • Direct Energy Marketing Ltd:電力:M&Aディール及び事業提携情報
    Summary Direct Energy Marketing Ltd (Direct Energy), a subsidiary of Centrica plc, is a provider of energy and energy-related services. The company supplies, transports, and distributes natural gas and electricity. Direct Energy also installs and maintains heating, ventilation and air conditioning ( …
  • Gulfport Energy Corp (GPOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Utica Shale, West Cote Blanche Bay Field, Hackberry Field, Athabasca, Peace River oil and Cold Lake o …
  • Chubb European Group SE:企業の戦略的SWOT分析
    Chubb European Group SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • Travis Perkins plc:企業の戦略・SWOT・財務分析
    Travis Perkins plc - Strategy, SWOT and Corporate Finance Report Summary Travis Perkins plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆